Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Pharma-Bio Serv (PBSV) Shares Repurchased (2016 - 2026)

Pharma-Bio Serv filings provide 13 years of Shares Repurchased readings, the most recent being $1681.0 for Q1 2026.

  • On a quarterly basis, Shares Repurchased changed N/A to $1681.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $33124.0, a 713.86% increase, with the full-year FY2025 number at $31443.0, up 179.17% from a year prior.
  • Shares Repurchased hit $1681.0 in Q1 2026 for Pharma-Bio Serv, down from $9202.0 in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $55159.0 in Q1 2022 to a low of $792.0 in Q4 2023.
  • Median Shares Repurchased over the past 5 years was $6138.0 (2023), compared with a mean of $11480.2.
  • Biggest five-year swings in Shares Repurchased: tumbled 91.84% in 2024 and later skyrocketed 642.01% in 2025.
  • Pharma-Bio Serv's Shares Repurchased stood at $2379.0 in 2022, then crashed by 66.71% to $792.0 in 2023, then surged by 120.58% to $1747.0 in 2024, then soared by 426.73% to $9202.0 in 2025, then crashed by 81.73% to $1681.0 in 2026.
  • The last three reported values for Shares Repurchased were $1681.0 (Q1 2026), $9202.0 (Q4 2025), and $5004.0 (Q3 2025) per Business Quant data.